مجله علوم پزشکی پارس

ارتباط پلی‌مورفیسم ژن Beta fibrinogen-455 G/A(rs1800790) با سقط مکرر در زنان ایرانی

نویسندگان

1 استاد، مرکز تحقیقات علوم دارویی،گروه سم شناسی و فارماکولوژی، دانشکده داروسازی، دانشگاه علوم پزشکی مازندران، ساری، ایران

2 دکترای سلولی و مولکولی، مرکز تحقیقات علوم دارویی،گروه سم شناسی و فارماکولوژی، دانشکده داروسازی،دانشگاه علوم پزشکی مازندران، ساری، ایران

3 دانشجوی کارشناسی ارشد، گروه ژنتیک، موسسه آموزش عالی سنا، ساری، ایران

چکیده

زمینه و هدف :  سقط مکرر یک اختلال ژنتیکی با علل مختلف است که طبق تعریف سازمان بهداشت جهانی، به سه بار یا بیشتر از دست دادن حاملگی گفته می شود. ناهنجاری های ژنتیکی یکی از علل اصلی سقط مکرر است. هدف پژوهش حاضر بررسی ارتباط پلی مورفیسم ژن Beta fibrinogen (rs1800790) و سقط مکرر در زنان ایرانی بود.
روش بررسی : در این مطالعه ی مورد– شاهدی101 زن دچار سقط مکرر (41-19 سال) و 50 زن بدون سابقه سقط (57-23 سال) (کنترل) شرکت داشتند. پنج میلی لیتر از خون این افراد در لوله های حاوی EDTA در بیمارستان امام خمینی شهر ساری طی سال های 1397-1396 جمع آوری شد. DNA ژنومی با روش salting out استخراج و به روش PCR-RFLP بررسی ژنوتیپی پلی مورفیسم انجام شد. داده ها با استفاده از نرم افزار Medcalc نسخه 15 تحلیل آماری شدند.
یافته ها : شیوع فراوانی ژنوتیپی GG ,GA ,AA ژن FGB به ترتیب در گروه بیمار 5.94% ، 29.7% ، 64.36%، و در گروه کنترل 2% ، 50% ، 48% بود(p=0.040). درصد فراوانی اللی G و A به ترتیب در گروه بیمار 79% و 21% و در گروه کنترل 73% و 27% بود (p=0.322). شواهد نشان داد ژن موتانت AA ، خطر سقط مکرر را افزایش نمی دهد و ارتباط معناداری وجود ندارد (p=0.472). اما هتروزیگوت GA  نسبت به ژنوتیپ مرجع GG خطر سقط مکرر را کاهش می دهد (OR=0.44, 95%CI:0.22-0.90)(p=0.024).
نتیجه گیری :  نتایج نشان داد که پلی مورفیسم  rs1800790 ژن FGB، خطر بروز سقط مکرر را افزایش نمی دهد.

کلیدواژه‌ها

عنوان مقاله [English]

The association of beta fibrinogen-455 G/A (rs1800790) gene polymorphism with recurrent abortion in Iranian women

نویسندگان [English]

  • Mohammad Shokrzadeh 1
  • Abbas Mohammadpour 2
  • Zeinab Heidari 3

1 Professor, pharmacutical research center, department of Toxicology and pharmacology, faculty of pharmacy, mazandaran university of medical sciences, sari, Iran

2 Ph.D cell &molecular biology, pharmacutical research center, department of toxicology and pharmacology, faculty of pharmacy, mazandaran university of medical sciences, sari, Iran

3 Graduate student of genetics, Sana Institute of Higher Education, Sari, Iran

چکیده [English]

Introduction: Recurrent Abortion is a genetic disorder with different etiologies, as defined by the World Health
Organization (WHO), three or more times consecutive pregnancy losses. Genetic anomalies are one of the main etiologies of recurrent abortion. The purpose of the study was to investigate the association between beta fibrinogen (rs1800790) gene polymorphism and recurrent abortion in Iranian women.
Materials and Methods: In this case-control study, 101 women with recurrent abortion (19-41 years) and 50 women with no history of abortion (23-57 years) (controls) were present. Five milliliters of their blood was collected in EDTA tubes in Imam Khomeini hospital, Sari, Iran, during 2017-2018. Genomic DNA was extracted using salting-out method and genotypic study of polymorphism was performed using PCR-RFLP method. Statistical analysis was performed using Medcalc software version 15.
Results: Relative frequency of AA, GA, GG genotypes for FGB in patient group were 5.94%, 29.7% and 64.36% and in control group were 2%, 50%, 48% respectively (p= 0.040). The percentage of G and A alleles was 79% and 21% in patient and 73% and 27% in control groups, respectively (p= 0.322). Evidence indicated the AA mutant gene does not increase the risk of recurrent abortion and there is no significant association (p= 0.472). But GA heterozygote relative to GG reference genotype decrease the risk of recurrent abortion (OR= 0.44, 95%CI: 0.22-0.90, P= 0.024).
Conclusion: The results showed that rs1800790 FGB gene polymorphism did not increase the risk of recurrent
abortion.

کلیدواژه‌ها [English]

  • Rs1800790
  • Recurrent abortion
  • Beta Fibrinogen- 455 G/A
1- Li, jie. Wu, hongbo. Chen, yang. Wu, huimei. Xu, hong. Li, liuming. Genetic association between F VIII and β-fibrinogen genes and women with recurrent spontaneous abortion: a meta analysis.J assist reprod genet.2015.32:817-825. 2- Singh N , Gandhi M . Altered Levels of Fibrinogen in Relation to the Pathophysiology of Recurrent Spontaneous Abortions . WebmedCentral Obstetrics And Gynaecology 2011;2(6):WMC001964. 3- Laskin CA, Spitzer KA, Clark CA, Crowther MR, Ginsberg JS, Hawker GA, et al. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASATrial. J Rheumatol. 2009;36:279–87. 4- Poursadegh Zonouzi .A, chaparzadeh.N,ghorbanian.s, farzadi.L, ghasemzadeh.A, kafshdooz.T, et al.The association between thrombophilic gene mutations and recurrent pregnancy loss. J Assist Reprod Genet. 2013.30:1353-1359. 5- Ford HB, Schust DJ. Recurrent pregnancy loss: etiology, diagnosis, and therapy. Rev Obstet Gynecol. 2009;2:76–83. 6- Kamali.M , Hantoushzadeh.S, Borna.S, Neamatzadeh.H , Mazaheri.M , Noori-Shadkam.M and Haghighi.F. Association between Thrombophilic Genes Polymorphisms and Recurrent Pregnancy Loss Susceptibility in the Iranian Population: a Systematic Review and Meta-Analysis. Iranian Biomedical Journal.2018. 22(2): 78-89. 7- Mashayekhi. A, shahbazi. SH.evaluation of the association between FGBrs1800790 and plasma fibrinogen levels. Sci J Iran Blood Transfus Organ 2014; 11(1): 48-55. 8- Bin Q, Liang F, Ou DY, et al.Two symptomatic cases of dysfibrinogenemia in China: one with gamma-chain Arg275Cys mutation and another without detectable mutation in fibrinogen genes. Blood Coagul Fibrinolysis.2015;26:564–571. 9- Jeddi-Tehrani M, Torabi R, Zarnani AH, Mohammadzadeh A, Arefi S, Zeraati H, et al. Analysis of plasminogen activator inhibitor-1, integrin beta3, beta fibrinogen, and methylenetetrahydrofolate reductase polymorphisms in Iranian women with recurrent pregnancy loss. Am J Reprod Immunol. 2011;66(2):149–56. 10- Kiwi R. Recurrent pregnancy loss: evaluation and discussion of the causes and their management. Cleve Clin J Med 2006;73(10):913-21. 11- Erdem HB, ceylan A C, kaya A, bahsi A, erdem Z S , sahin I, et al.positive correlation between Platelet Parameters and Genetic Markers of thrombophilia panel in Recurrent Pregnancy Loss. Euras J Fam Med.2018;7(1):19-28. 12- Gie Ken.Dror ,Steve E. Humphries ,Meena Kumari , Mika Kivimaki , Fotios Drenos. A genetic instrument for Mendelian randomization of fibrinogen. Eur J Epidemiol 2012.27:267–279. 13- Retha C. Kotzé Cornelie Nienaber‐Rousseau Zelda De Lange Moniek P. De Maat Tiny Hoekstra Marlien Pieters. Genetic polymorphisms influencing total and γ′ fibrinogen levels and fibrin clot properties in Africans.british journal of haematology.2015:volume168, Issue1 Pages 102-112. 14- Shakuri GS , Shokrzadeh M ,Naji T,Hosseini V, Haghi AH , Alizadeh A,et al. Evaluation of GST-T1 Gene Polymorphism in Chronic Hepatitis B Infection . 2014 ; 24(115) : 52-59 .(persian) 15- Yenicesu I, Cetin M, Ozdemir O, Cetin A, Ozen F, Yenicesu C, et al. A prospective case–control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss. Am J Reprod Immunol. 2010;63:126–36. 16- Ozdemir. O, yenicesu. G I, salin. F, koksal.B, atik.S, ozen.F, et al. recurrent pregnancy loss and its relation to combined parental thrombophilic gene mutations. Genetic Testing And Molecular Biomarkers.2012: Volume 16, Number 4. 17- Maziri P, Asaadi Tehrani G, Bahrami Hidagi F, Nejatollahi M, Asadi S. Association between Thrombophilic Gene Polymorphisms and Recurrent Pregnancy Loss in Iranian Women. Iranian Journal of Neonatology. 2017 Dec: 8(4). 18- Bigdeli,R., Younesi, M., Panahnejad,E., Asgary,V., Heidarzadeh,S., Mazaheri,H and Louni Aligoudarzi,S. .Association between thrombophilia gene polymorphisms and recurrent pregnancy loss risk in the Iranian population, Systems Biology in Reproductive Medicine,2018 : DOI: 10.1080/19396368.2018.1456576. 19- Yehia A. Wafa, Tamer F. Oof, Rabei A. Hassanein, Mohamed I. Farahat. Relationship Between Plasminogen Activator Inhibitor-1 (Pai-1) And Beta Fibrinogen Polymorphisms With Unexplained Recurrent Pregnancy Loss. Med. J. Cairo Univ.2016: Vol. 84, No. 3. 20- Chatzidimitriou ,M. Chatzidimitriou ,D. Mavridou, M. Anetakis, C. Chatzopoulou, F. Lialiaris ,T. Mitka, S.Thrombophilic gene polymorphisms and recurrent pregnancy loss in Greek women. Int J Lab Hematol.2017: 39(6).590-596. 21- Torabi R, Zarei S, Zeraati H, Zarnani AH, Akhondi MA, Hadavi R, et al. Combination of Thrombophilic Gene Polymorphisms as a Cause of Increased the Risk of Recurrent Pregnancy Loss. J Reprod Infertil. 2012;13(2):89-94.
مجله علوم پزشکی پارس
دوره 17، شماره 1 - شماره پیاپی 47
فروردین 1398
صفحه 56-62